ILT4 was upregulated in NSCLC with EGFR activation by EGFR-AKT/-ERK1/2 but not NF-κB signaling, which further blocked the infiltration and cytotoxicity of T cells (45). This evidence concerns the gene EGFR and non-small cell lung carcinoma.